Patients Seek Compensation in Ozempic Lawsuit Claims Against Novo Nordisk
Patients who have experienced severe side effects from the diabetes drug Ozempic are filing lawsuits against Novo Nordisk, claiming that the pharmaceutical company failed to warn them about the potential risks. While Ozempic is only approved by the FDA for treating type 2 diabetes, it has been used off-label for weight loss due to its effectiveness in reducing appetite and producing a feeling of fullness. However, the drug has been associated with various side effects, including gastroparesis (stomach paralysis), thyroid tumors or cancer, hypoglycemia, pancreatitis, and gallstones. The exact worth of each Ozempic claim is … Read more